A neonatal oral Mycobacterium tuberculosis-SIV prime/intramuscular MVA-SIV boost combination vaccine induces both SIV and Mtb-specific immune responses in infant macaques

Trials in Vaccinology

Volumn 2, Issue 1, 2013, Pages 53-63

  Jensen, Kara ^a   Dela Pena, Myra Grace ^a   Wilson, Robert L ^b   Ranganathan, Uma Devi K ^c   Jacobs, William R ^c   Fennelly, Glenn ^c   Larsen, Michelle ^c   Van Rompay, Koen K A ^d   Kozlowski, Pamela A ^b   Abel, Kristina ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

HIV; Immunogenicity; Neonatal macaque model; TB; Vaccine

Indexed keywords

BACTERIAL VACCINE; MYCOBACTERIUM TUBERCULOSIS SIMIAN IMMUNODEFICIENCY VIRUS VACCINE; MYCOBACTERIUM TUBERCULOSIS VACCINE; SIMIAN IMMUNODEFICIENCY VIRUS VACCINE; UNCLASSIFIED DRUG;

ADAPTIVE IMMUNITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST FEEDING; CELLULAR IMMUNITY; CHEMICAL ENGINEERING; CONTROLLED STUDY; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; IMMUNOGENICITY; LYMPH NODE; MACAQUE MODEL; MOTHER; MYCOBACTERIUM TUBERCULOSIS; NEWBORN; NONHUMAN; PRIORITY JOURNAL; RHESUS MONKEY; TUBERCULOSIS;

EID: 84889084961     PISSN: None     EISSN: 18794378     Source Type: Journal    
DOI: 10.1016/j.trivac.2013.09.005     Document Type: Article

References (49)

1. http://www.unaids.org, posting date, (online).
2. M. Adhikari, P. Jeena, R. Bobat, M. Archary, K. Naidoo, A. Coutsoudis, R. Singh, and N. Nair HIV-associated tuberculosis in the newborn and young infant Int. J. Pediatr. 2011 2011 354208
3. S.S. Nair Ethical aspects of the revised national tuberculosis control programme Indian J. Med. Ethics 8 2011 102 106
4. A.C. Hesseling, B.J. Marais, R.P. Gie, H.S. Schaaf, P.E. Fine, P. Godfrey-Faussett, and N. Beyers The risk of disseminated Bacille Calmette-Guerin (BCG) disease in HIV-infected children Vaccine 25 2007 14 18 (Pubitemid 44855247)
5. N. Saubi, A. Mbewe-Mvula, E. Gea-Mallorqui, M. Rosario, J.M. Gatell, T. Hanke, and J. Joseph Pre-clinical development of BCG.HIVA(CAT), an antibiotic-free selection strain, for HIV-TB pediatric vaccine vectored by lysine auxotroph of BCG PLoS ONE 7 2012 e42559
6. R. Hopkins, A. Bridgeman, J. Joseph, S.C. Gilbert, H. McShane, and T. Hanke Dual neonate vaccine platform against HIV-1 and M. tuberculosis PLoS ONE 6 2011 e20067
7. N. Saubi, E.J. Im, R. Fernandez-Lloris, O. Gil, P.J. Cardona, J.M. Gatell, T. Hanke, and J. Joseph Newborn mice vaccination with BCG.HIVA(2)(2)(2) + MVA.HIVA enhances HIV-1-specific immune responses: influence of age and immunization routes Clin. Dev. Immunol. 2011 2011 516219
8. M. Rosario, R. Hopkins, J. Fulkerson, N. Borthwick, M.F. Quigley, J. Joseph, D.C. Douek, H.Y. Greenaway, V. Venturi, E. Gostick, D.A. Price, G.W. Both, J.C. Sadoff, and T. Hanke Novel recombinant Mycobacterium bovis BCG, ovine atadenovirus, and modified vaccinia virus Ankara vaccines combine to induce robust human immunodeficiency virus-specific CD4 and CD8 T-cell responses in rhesus macaques J. Virol. 84 2010 5898 5908
9. M.J. Cayabyab, B. Korioth-Schmitz, Y. Sun, A. Carville, H. Balachandran, A. Miura, K.R. Carlson, A.P. Buzby, B.F. Haynes, W.R. Jacobs, and N.L. Letvin Recombinant Mycobacterium bovis BCG prime-recombinant adenovirus boost vaccination in rhesus monkeys elicits robust polyfunctional simian immunodeficiency virus-specific T-cell responses J. Virol. 83 2009 5505 5513
10. R. Hopkins, A. Bridgeman, C. Bourne, A. Mbewe-Mvula, J.C. Sadoff, G.W. Both, J. Joseph, J. Fulkerson, and T. Hanke Optimizing HIV-1-specific CD8(+) T-cell induction by recombinant BCG in prime-boost regimens with heterologous viral vectors Eur. J. Immunol. 41 2011 3542 3552
11. E.J. Im, N. Saubi, G. Virgili, C. Sander, D. Teoh, J.M. Gatell, H. McShane, J. Joseph, and T. Hanke Vaccine platform for prevention of tuberculosis and mother-to-child transmission of human immunodeficiency virus type 1 through breastfeeding J. Virol. 81 2007 9408 9418 (Pubitemid 47311483)
12. M. Rosario, J. Fulkerson, S. Soneji, J. Parker, E.J. Im, N. Borthwick, A. Bridgeman, C. Bourne, J. Joseph, J.C. Sadoff, and T. Hanke Safety and immunogenicity of novel recombinant BCG and modified vaccinia virus Ankara vaccines in neonate rhesus macaques J. Virol. 84 2010 7815 7821
13. P. Brodin, L. Majlessi, L. Marsollier, M.I. de Jonge, D. Bottai, C. Demangel, J. Hinds, O. Neyrolles, P.D. Butcher, C. Leclerc, S.T. Cole, and R. Brosch Dissection of ESAT-6 system 1 of Mycobacterium tuberculosis and impact on immunogenicity and virulence Infect. Immun. 74 2006 88 98 (Pubitemid 43023062)
14. D.C. Dillon, M.R. Alderson, C.H. Day, T. Bement, A. Campos-Neto, Y.A. Skeiky, T. Vedvick, R. Badaro, S.G. Reed, and R. Houghton Molecular and immunological characterization of Mycobacterium tuberculosis CFP-10, an immunodiagnostic antigen missing in Mycobacterium bovis BCG J. Clin. Microbiol. 38 2000 3285 3290
15. K. Jensen, U.D. Ranganathan, K.K. Van Rompay, D.R. Canfield, I. Khan, R. Ravindran, P.A. Luciw, W.R. Jacobs Jr., G. Fennelly, M.H. Larsen, and K. Abel A recombinant attenuated Mycobacterium tuberculosis vaccine strain is safe in immunosuppressed simian immunodeficiency virus-infected infant macaques Clin. Vaccine Immunol. 19 2012 1170 1181
16. S.A. Sharpe, H. McShane, M.J. Dennis, R.J. Basaraba, F. Gleeson, G. Hall, A. McIntyre, K. Gooch, S. Clark, N.E. Beveridge, E. Nuth, A. White, A. Marriott, S. Dowall, A.V. Hill, A. Williams, and P.D. Marsh Establishment of an aerosol challenge model of tuberculosis in rhesus macaques and an evaluation of endpoints for vaccine testing Clin. Vaccine Immunol. 17 2010 1170 1182
17. J. Zhang, Y.Q. Ye, Y. Wang, P.Z. Mo, Q.Y. Xian, Y. Rao, R. Bao, M. Dai, J.Y. Liu, M. Guo, X. Wang, Z.X. Huang, L.H. Sun, Z.J. Tang, and W.Z. Ho M. tuberculosis H37Rv infection of Chinese rhesus macaques J. Neuroimmune Pharmacol. 6 2011 362 370
18. D.N. McMurray A nonhuman primate model for preclinical testing of new tuberculosis vaccines Clin. Infect. Dis. 30 Suppl. 3 2000 S210 212
19. S. Mehra, N.A. Golden, N.K. Dutta, C.C. Midkiff, X. Alvarez, L.A. Doyle, M. Asher, K. Russell-Lodrigue, C. Monjure, C.J. Roy, J.L. Blanchard, P.J. Didier, R.S. Veazey, A.A. Lackner, and D. Kaushal Reactivation of latent tuberculosis in rhesus macaques by co-infection with simian immunodeficiency virus J. Med. Primatol. 40 2011 233 243
20. H. Safi, B.J. Gormus, P.J. Didier, J.L. Blanchard, D.L. Lakey, L.N. Martin, M. Murphey-Corb, R. Vankayalapati, and P.F. Barnes Spectrum of manifestations of Mycobacterium tuberculosis infection in primates infected with SIV AIDS Res. Hum. Retroviruses 19 2003 585 595 (Pubitemid 36900577)
21. Y. Shen, D. Zhou, L. Chalifoux, L. Shen, M. Simon, X. Zeng, X. Lai, Y. Li, P. Sehgal, N.L. Letvin, and Z.W. Chen Induction of an AIDS virus-related tuberculosis-like disease in macaques: a model of simian immunodeficiency virus-mycobacterium co-infection Infect. Immun. 70 2002 869 877 (Pubitemid 34083851)
22. + T cell responses in SIV infection J. Exp. Med. 206 2009 923 936
23. C. Sun, Z. Chen, X. Tang, Y. Zhang, L. Feng, Y. Du, L. Xiao, L. Liu, W. Zhu, L. Chen, and L. Zhang Mucosal priming with a replicating-vaccinia virus-based vaccine elicits protective immunity to simian immunodeficiency virus challenge in rhesus monkeys J. Virol. 87 2013 5669 5677
24. K.E. Stephenson, H. Li, B.D. Walker, N.L. Michael, and D.H. Barouch Gag-specific cellular immunity determines in vitro viral inhibition and in vivo virologic control following simian immunodeficiency virus challenges of vaccinated rhesus monkeys J. Virol. 86 2012 9583 9589
25. + T cell responses against human immunodeficiency virus type 1 Env and M. tuberculosis in neonatal mice Vaccine 28 2009 152 161
26. M.H. Larsen, K. Biermann, B. Chen, T. Hsu, V.K. Sambandamurthy, A.A. Lackner, P.P. Aye, P. Didier, D. Huang, L. Shao, H. Wei, N.L. Letvin, R. Frothingham, B.F. Haynes, Z.W. Chen, and W.R. Jacobs Jr. Efficacy and safety of live attenuated persistent and rapidly cleared Mycobacterium tuberculosis vaccine candidates in non-human primates Vaccine 27 2009 4709 4717
27. V.K. Sambandamurthy, S.C. Derrick, T. Hsu, B. Chen, M.H. Larsen, K.V. Jalapathy, M. Chen, J. Kim, S.A. Porcelli, J. Chan, S.L. Morris, and W.R. Jacobs Jr. Mycobacterium tuberculosis DeltaRD1 DeltapanCD: a safe and limited replicating mutant strain that protects immunocompetent and immunocompromised mice against experimental tuberculosis Vaccine 24 2006 6309 6320 (Pubitemid 44247236)
28. V.K. Sambandamurthy, X. Wang, B. Chen, R.G. Russell, S. Derrick, F.M. Collins, S.L. Morris, and W.R. Jacobs Jr. A pantothenate auxotroph of Mycobacterium tuberculosis is highly attenuated and protects mice against tuberculosis Nat. Med. 8 2002 1171 1174 (Pubitemid 35175974)
29. W.R. Waters, M.V. Palmer, B.J. Nonnecke, T.C. Thacker, C.F. Scherer, D.M. Estes, R.G. Hewinson, H.M. Vordermeier, S.W. Barnes, G.C. Federe, J.R. Walker, R.J. Glynne, T. Hsu, B. Weinrick, K. Biermann, M.H. Larsen, and W.R. Jacobs Jr. Efficacy and immunogenicity of Mycobacterium bovis DeltaRD1 against aerosol M. bovis infection in neonatal calves Vaccine 27 2009 1201 1209
30. D.M. Zimmerman, W.R. Waters, K.P. Lyashchenko, B.J. Nonnecke, D.L. Armstrong, W.R. Jacobs Jr., M.H. Larsen, E. Egan, and G.A. Dean Safety and immunogenicity of the Mycobacterium tuberculosis DeltalysA DeltapanCD vaccine in domestic cats infected with feline immunodeficiency virus Clin. Vaccine Immunol. 16 2009 427 429
31. P.L. Earl, L.S. Wyatt, D.C. Montefiori, M. Bilska, R. Woodward, P.D. Markham, J.D. Malley, T.U. Vogel, T.M. Allen, D.I. Watkins, N. Miller, and B. Moss Comparison of vaccine strategies using recombinant env-gag-pol MVA with or without an oligomeric Env protein boost in the SHIV rhesus macaque model Virology 294 2002 270 281 (Pubitemid 34920525)
32. K.K. Van Rompay, K. Abel, J.R. Lawson, R.P. Singh, K.A. Schmidt, T. Evans, P. Earl, D. Harvey, G. Franchini, J. Tartaglia, D. Montefiori, S. Hattangadi, B. Moss, and M.L. Marthas Attenuated poxvirus-based simian immunodeficiency virus (SIV) vaccines given in infancy partially protect infant and juvenile macaques against repeated oral challenge with virulent SIV J. Acquir. Immune Defic. Syndr. 38 2005 124 134 (Pubitemid 40189318)
33. N. Winstone, A.J. Wilson, G. Morrow, C. Boggiano, M.J. Chiuchiolo, M. Lopez, M. Kemelman, A.A. Ginsberg, K. Mullen, J.W. Coleman, C.D. Wu, S. Narpala, I. Ouellette, H.J. Dean, F. Lin, N.Y. Sardesai, H. Cassamasa, D. McBride, B.K. Felber, G.N. Pavlakis, A. Schultz, M.G. Hudgens, C.R. King, T.J. Zamb, C.L. Parks, and A.B. McDermott Enhanced control of pathogenic Simian immunodeficiency virus SIVmac239 replication in macaques immunized with an interleukin-12 plasmid and a DNA prime-viral vector boost vaccine regimen J. Virol. 85 2011 9578 9587
34. M.L. Marthas, K.K. Van Rompay, Z. Abbott, P. Earl, L. Buonocore-Buzzelli, B. Moss, N.F. Rose, J.K. Rose, P.A. Kozlowski, and K. Abel Partial efficacy of a VSV-SIV/MVA-SIV vaccine regimen against oral SIV challenge in infant macaques Vaccine 29 2011 3124 3137
35. P.A. Kozlowski, R.M. Lynch, R.R. Patterson, S. Cu-Uvin, T.P. Flanigan, and M.R. Neutra Modified wick method using Weck-Cel sponges for collection of human rectal secretions and analysis of mucosal HIV antibody J. Acquir. Immune Defic. Syndr. 24 2000 297 309
36. F. Abebe, and G. Bjune The protective role of antibody responses during Mycobacterium tuberculosis infection Clin. Exp. Immunol. 157 2009 235 243
37. A.M. Cooper Host versus pathogen: two sides of the same challenge in the TB world Eur. J. Immunol. 39 2009 632 633
38. J. Zuniga, D. Torres-Garcia, T. Santos-Mendoza, T.S. Rodriguez-Reyna, J. Granados, and E.J. Yunis Cellular and humoral mechanisms involved in the control of tuberculosis Clin. Dev. Immunol. 2012 2012 193923
39. J.R. Mascola, and B.F. Haynes HIV-1 neutralizing antibodies: understanding nature's pathways Immunol. Rev. 254 2013 225 244
40. S.G. Hansen, J.C. Ford, M.S. Lewis, A.B. Ventura, C.M. Hughes, L. Coyne-Johnson, N. Whizin, K. Oswald, R. Shoemaker, T. Swanson, A.W. Legasse, M.J. Chiuchiolo, C.L. Parks, M.K. Axthelm, J.A. Nelson, M.A. Jarvis, M. Piatak Jr., J.D. Lifson, and L.J. Picker Profound early control of highly pathogenic SIV by an effector memory T-cell vaccine Nature 473 2011 523 527
41. K. Kleinsteuber, K. Heesch, S. Schattling, C. Sander-Juelch, U. Mock, K. Riecken, B. Fehse, B. Fleischer, and M. Jacobsen SOCS3 promotes interleukin-17 expression of human T cells Blood 120 2012 4374 4382
42. X. Wang, P.F. Barnes, F. Huang, I.B. Alvarez, P.F. Neuenschwander, D.R. Sherman, and B. Samten Early secreted antigenic target of 6-kDa protein of Mycobacterium tuberculosis primes dendritic cells to stimulate Th17 and inhibit Th1 immune responses J. Immunol. 189 2012 3092 3103
43. J.M. Pitt, E. Stavropoulos, P.S. Redford, A.M. Beebe, G.J. Bancroft, D.B. Young, and A. O'Garra Blockade of IL-10 signaling during Bacillus Calmette-Guerin vaccination enhances and sustains Th1, Th17, and innate lymphoid IFN-gamma and IL-17 responses and increases protection to Mycobacterium tuberculosis infection J. Immunol. 189 2012 4079 4087
44. R. Gopal, J. Rangel-Moreno, S. Slight, Y. Lin, H.F. Nawar, B.A. Fallert Junecko, T.A. Reinhart, J. Kolls, T.D. Randall, T.D. Connell, and S.A. Khader Interleukin-17-dependent CXCL13 mediates mucosal vaccine-induced immunity against tuberculosis Mucosal Immunol. 6 2013 972 984
45. B.F. Haynes, P.B. Gilbert, M.J. McElrath, S. Zolla-Pazner, G.D. Tomaras, S.M. Alam, D.T. Evans, D.C. Montefiori, C. Karnasuta, R. Sutthent, H.X. Liao, A.L. DeVico, G.K. Lewis, C. Williams, A. Pinter, Y. Fong, H. Janes, A. DeCamp, Y. Huang, M. Rao, E. Billings, N. Karasavvas, M.L. Robb, V. Ngauy, M.S. de Souza, R. Paris, G. Ferrari, R.T. Bailer, K.A. Soderberg, C. Andrews, P.W. Berman, N. Frahm, S.C. De Rosa, M.D. Alpert, N.L. Yates, X. Shen, R.A. Koup, P. Pitisuttithum, J. Kaewkungwal, S. Nitayaphan, S. Rerks-Ngarm, N.L. Michael, and J.H. Kim Immune-correlates analysis of an HIV-1 vaccine efficacy trial N. Engl. J. Med. 366 2012 1275 1286
46. D.N. Forthal, G. Landucci, M.K. Gorny, S. Zolla-Pazner, and W.E. Robinson Jr. Functional activities of 20 human immunodeficiency virus type 1 (HIV-1)-specific human monoclonal antibodies AIDS Res. Hum. Retroviruses 11 1995 1095 1099
47. R.M. Ruprecht, F. Ferrantelli, M. Kitabwalla, W. Xu, and H.M. McClure Antibody protection: passive immunization of neonates against oral AIDS virus challenge Vaccine 21 2003 3370 3373 (Pubitemid 36792088)
48. K.K. Van Rompay, C.J. Berardi, S. Dillard-Telm, R.P. Tarara, D.R. Canfield, C.R. Valverde, D.C. Montefiori, K.S. Cole, R.C. Montelaro, C.J. Miller, and M.L. Marthas Passive immunization of newborn rhesus macaques prevents oral simian immunodeficiency virus infection J. Infect. Dis. 177 1998 1247 1259 (Pubitemid 28194263)
49. D. Forthal, T.J. Hope, and G. Alter New paradigms for functional HIV-specific non-neutralizing antibodies Curr. Opin. HIV AIDS 8 2013 392 400